New Genetic Discovery Could Boost Cancer Immunotherapy
A recent genetic discovery has the potential to boost the effectiveness of cancer immunotherapy treatments. According to a study published in the journal Nature, the genetic discovery may improve cancer treatment outcomes in certain patients. Researchers stumbled upon the promising clue while they studied treatment outcomes in ovarian clear cell carcinoma (OCCC) patients post-immunotherapy. The study was co-authored by Emily Hinchcliff, MD, an assistant professor of Obstetrics and Gynecology at Northwestern Medicine's Division of Gynecologic Oncology. She notes that conventional cancer treatments such as radiation and chemotherapy are rarely effective against OCCC, an aggressive but rare form of ovarian cancer…

